Breaking the “rule-of-five” to access Bridged Bicyclic Heteroaromatic Bioisosteres

30 May 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Bioisosteric replacement of aromatic and heteroaromatic rings with bridged bicyclic hydrocarbons is an important strategy in drug discovery. Intramolecular [2+2] cycloadditions of unconjugated dienes provide an efficient route to these motifs but are governed by the “rule-of-five”, which dictates that five-membered rings are preferentially formed, therefore limiting access to alternative ring sizes. Herein, we introduce a visible light-mediated intramolecular [2+2] cycloaddition of aza-1,6-dienes that leverages radical stabilisation strategies to successfully challenge this paradigm and enable the selective formation of bridged bicycles over traditionally favoured fused bicycles. This provides previously elusive 6-azabicyclo[3.1.1]heptanes (6-N-BCHeps), which serve as bioisosteric mimetics for both nitrogen-containing aromatics and saturated six-membered ring heterocycles. Notably, this work represents the first general synthesis of substituted 6-N-BCHeps, enabling facile substitution at every position around the ring. Exit vector analysis and comparison of the physicochemical and pharmacological properties of a 6-N-BCHep analogue of a piperazine-based drug demonstrate the potential application of this scaffold in medicinal chemistry. The methodology offers a powerful strategy for exploring new chemical space, with broad implications for drug discovery and beyond.

Keywords

Bridged Bicyclic Heteroaromatics
Bioisosteres
rule-of-five
photochemistry
energy transfer

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.